NBE-Therapeutics obtained CHF 600K SystemsX grant for collaboration with clinical oncologists

NBE-Therapeutics is industry partner in a Swiss SystemsX funded transfer-project together with Prof. Zippelius of University Hospital Basel and Prof. Reddy of ETH

NBE-Therapeutics today announced that it has been awarded a grant for a transfer project of CHF 600K volume supported by the Swiss federal SystemsX initiative (see: http://www.systemsx.ch/). The grant is intended to support a collaboration of NBE-Therapeutics together with the group of Prof. Alfred Zippelius from the Department Biomedicine and the Clinical Oncology of the University Hospital Basel, as the lead academic investigator, and the group of Prof. Sai Reddy at the Basel-based Department for Biosystems Science and Engineering (D-BSSE) of ETH-Zurich. The collaboration is focused on studying synergies between antibody drug conjugate-based therapy developed by NBE-Therapeutics with other immune-therapeutic interventions, in order to find the most effective therapies for cancer patients.